TrialInternational clinical psychopharmacology2014

Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorder.

Jean-Philippe Boulenger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.